Conversely, compounds such as selective benzodiazepines used widely for a variety of neurological issues were found to enhance the aggregation and cytotoxicity of PIMAX p-tau [58], suggesting that certain risk factors for AD and AD-related dementia can be identified via the use of PIMAX p-tau [65, 66]. This evidence concerns the gene MAPT and Alzheimer disease.